[On prevention of erythroblastosis with corpus luteum hormone, antihistaminics and vitamin K].
D018926:Anti-Allergic Agents; D000933:Antifibrinolytic Agents; D003339:Corpus Luteum Hormones; D004899:Erythroblastosis, Fetal / Q000517:prevention & control*; D006634:Histamine H1 Antagonists / Q000627:therapeutic use*; D006801:Humans; D007231:Infant, Newborn; D011374:Progesterone / Q000627:therapeutic use*; D014812:Vitamin K / Q000627:therapeutic use*
D018926:Anti-Allergic Agents; D000933:Antifibrinolytic Agents; D003339:Corpus Luteum Hormones; D006634:Histamine H1 Antagonists; D014812:Vitamin K; D011374:Progesterone
ANTIHISTAMINICS/therapeutic use; ERYTHROBLASTOSIS, FETAL/prevention and control; PROGESTERONE/therapeutic use; VITAMIN K/therapeutic use
Zur Frage der Erythroblastoseprophylaxe mit Corpus-luteum-Hormon, Antihistaminpräparaten und Vitamin K.